Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT04681677
Title Recurrent GBM Treated With Neurosurgical Resection and IORT Using the Xoft Axxent eBx System and Bevacizumab (IORT)
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Xoft, Inc.
Age Groups: adult | senior
Covered Countries USA

No variant requirements are available.